TIDMSENS

RNS Number : 1647B

Sensyne Health PLC

06 October 2020

Annual Report and Accounts and Notice of Annual General Meeting

Oxford, U.K. 06 October 2020 : Sensyne Health plc (LSE: SENS) ("Sensyne" or the "Company" or the "Group"), the UK Clinical AI company, announces that its Annual Report and Accounts for the year ended 30 April 2020 is now available on the Group's website at https://www.sensynehealth.com/investors/investor-hub

Copies of the Annual Report and Accounts will be posted later today to those shareholders that have elected to receive paper communications.

The Company also announces that its Notice of Annual General Meeting has been posted to shareholders today. The Annual General Meeting will be held virtually on 30 October 2020 at 1400 GMT.

As a result of current public health advice and "Stay at Home" guidance, the Company wishes to notify its shareholders that physical attendance in person at the AGM will not be possible.

-ENDS-

For more information please contact:

 
  Sensyne Health ( www.sensynehealth.com      +44 (0) 330 058 
   )                                           1845 
  Lord (Paul) Drayson PhD FREng FMedSci, 
   Chief Executive Officer 
  Michael Norris, Interim Chief Financial 
   Officer 
  Consilium Strategic Communications          +44 (0) 7780 600290 
  Mary-Jane Elliott 
  Sukaina Virji 
  Melissa Gardiner 
  CSC sensynehealth@consilium-comms.com

About Sensyne Health

Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).

For more information, please visit: www.sensynehealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSKKPBNDBDBOKK

(END) Dow Jones Newswires

October 06, 2020 02:00 ET (06:00 GMT)

Sensyne Health (LSE:SENS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Sensyne Health Charts.
Sensyne Health (LSE:SENS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Sensyne Health Charts.